Veloz-IT 10 Capsules

babies: not recommended. lactating mothers: may or may not be safe if prescribed.
please consult your doctor. pregnancy: it may or may not be safe if prescribed.
please consult your doctor. driving: it may be unsafe as it alters concentration by making you feel sleepy and dizzy. alcohol: highly unsafe as it may worsen the state of drowsiness.
kidney: dose adjustment may require in kidney impaired patients. please consult your doctor.
liver: dose adjustment may require in hepatic impaired patients. please consult your doctor..

Dizziness Headache Drowsiness Stomach pain Constipation Diarrhoea Flatulence Fatigue Increased saliva production .

VELOZ-IT capsule is given in combination for the treatment and management of gastro-oesophageal reflux disease (gerd) and peptic ulcer disease and helps in relieving its symptoms like heartburn, stomach pain and irritation caused due to the disease as it is a combination of a gastroprokinetic and a proton-pump inhibitor which produces their actions effectively. it promotes the movement in the stomach that helps in the easy passage of the food.
also, it inhibits an enzyme produced from a region of the brain that controls vomiting. it also helps reduce the gastric-acid secretions that prevent further damage to the ulcer present on the stomach lining and helps heal and reduce its symptoms like heartburn and indigestion..

If you miss any dose of this capsule, take VELOZ-IT for the next day on an empty stomach..

• VELOZ-IT is prescribed to treat and manage gastro-oesophageal reflux disease (gerd) and peptic ulcer disease. • long term use of this medication may weaken your bones due to deficiency of magnesium.
therefore, it is advised to take dietary calcium and magnesium, or you can ask your doctor to prescribe any nutritional supplements for it. • avoid foods that trigger heartburn and other symptoms of acidity.
• if you are suffering from gastro-oesophageal reflux disease, you need to have your dinner 3-4 hours prior to bedtime..

• itopride hcl + atropine: concurrent use may decrease the effects of itopride by pharmacodynamic antagonism. • itopride hcl + ipratropium: concurrent use may decrease the effects of itopride by pharmacodynamic antagonism.
• rabeprazole sodium + ketoconazole: concurrent use may decrease the effect of ketoconazole by increasing the gastric ph. • rabeprazole sodium + rilpivirine: concurrent use may decrease the effect of rilpivirine by increasing the gastric ph and cause treatment failure and may develop rilpivirine resistance..